Kathleen Green, PhD, Joseph L. Mayberry, Sr., Professor of Pathology and Toxicology, has received a Humboldt Research Award, which recognizes her achievements in epithelial cell biology and provides her the opportunity to visit Germany for research collaborations.
Northwestern Medicine investigators published the results of a clinical trial showing that a new psoriasis drug called guselkumab has greater efficacy than the current standard of care.
New Northwestern Medicine research shows spherical nucleic acids can silence a gene that interferes with wound healing, opening the door to new treatments for diabetic skin wounds, as well as many other conditions.
Northwestern Medicine scientists are testing a new flexible electronic material for safety on skin that could be used to collect noninvasive data for diagnosis of neurological disorders and brain-computer interfaces.
Northwestern Medicine scientists have discovered that scar-forming cells in scleroderma come from fat tissue within layers of the skin, a new cellular origin that could be a key to developing treatments for the incurable disease.
A Northwestern Medicine study analyzed the records of more than 20,000 surgeries and found a very low risk of adverse events for minimally-invasive cosmetic surgery procedures.
A Northwestern Medicine study found for the first time an increased risk of accidental injury for patients with eczema, a common itchy skin disorder.
Depleting an enzyme called GM3 synthase with gene therapy may help diabetics heal wounds faster.
The director of melanoma research within the Northwestern Skin Cancer Institute presented his validation study at a meeting of the American Academy of Dermatology.
Published in the Journal of Clinical Investigation, the lab of Kathleen Green, PhD, has discovered desmoglein 1’s role in promoting the skin’s differentiation program.